NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

Tvardi Therapeutics, Inc. ("Tvardi") , a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

May 13-15: Clinical Trial Supply Forum 2025. Kimi Oanh Le, Head of Clinical Trial Supply at Immunic, will discuss the clinical trial supply chain challenges working across the Middle East and North ...

There are no format restrictions ... when you are writing yours. Abstracts do not need to include references, parenthetical citations, footnotes, or a works cited page. Please proofread and rehearse ...

Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to demonstrate exceptional overall survival (OS) with a 2-year landmark ...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...

Getting published looks good on your medical school application and indicates that you can dig deep into research and follow through. It can also boost your residency and fellowship applications ...

2025 Student Symposium Format Students must choose between an oral presentation or a poster presentation ... For both options, students must first submit an abstract for approval by their faculty or ...

Canva Code is one of the newest features Canva is rolling out and I have to say, I find it genuinely helpful. With Canva Code ...

Premeds can get an edge by being published several ways, from hypothesis-based research papers to conference abstracts.